JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fathy, D. B.
Right arrow Articles by Leeb-Lundberg, L. M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fathy, D. B.
Right arrow Articles by Leeb-Lundberg, L. M. F.

J Biol Chem, Vol. 274, Issue 42, 29603-29606, October 15, 1999

COMMUNICATION
Spontaneous Human B2 Bradykinin Receptor Activity Determines the Action of Partial Agonists as Agonists or Inverse Agonists
EFFECT OF BASAL DESENSITIZATION

Dana B. Fathy, Tosso Leeb, Sandra A. Mathis, and L. M. Fredrik Leeb-Lundberg

From the Department of Biochemistry, The University of Texas Health Science Center, San Antonio, Texas 78284-7760

In this report, we show that desensitization regulates ligand-independent, spontaneous activity of the human B2 bradykinin (BK) receptor, and the level of spontaneous receptor activity determines the action of the BK antagonists and partial receptor agonists NPC17731 and HOE140 as agonists or inverse agonists. Spontaneous receptor activity was monitored by measuring basal cellular phosphoinositide (PI) hydrolysis as a function of the density of the receptor in transiently transfected HEK293 cells. Minimal spontaneous activity of the wild-type B2 receptor was detected in these cells. Mutating a cluster of serines and threonines within the fourth intracellular domain of the receptor, which is critical for agonist-promoted desensitization, significantly increased the spontaneous receptor activity. BK, the natural B2 receptor ligand and, consequently, a full agonist, stimulated PI hydrolysis at high and low levels of spontaneous receptor activity. On the other hand, the partial agonists NPC17731 and HOE140 were stimulatory, or agonists, at the lower level of receptor activity but inhibitory, or inverse agonists, at the higher level of activity. These results show that receptors are desensitized in response to their spontaneous activity. Furthermore, these results, which refute traditional theories, show that the capacity of a drug to modulate a receptor response is not intrinsic to the drug but is also dependent on the cellular environment in which the drug acts.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, J. Dunlop, T. Sanchez, M. Silva, and W. P. Clarke
A Conservative, Single-Amino Acid Substitution in the Second Cytoplasmic Domain of the Human Serotonin2C Receptor Alters Both Ligand-Dependent and -Independent Receptor Signaling
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1084 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Chachisvilis, Y.-L. Zhang, and J. A. Frangos
G protein-coupled receptors sense fluid shear stress in endothelial cells
PNAS, October 17, 2006; 103(42): 15463 - 15468.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Z. A. Pawluczyk, S. R. Patel, and K. P. G. Harris
The role of the {alpha}-1 adrenoceptor in modulating human mesangial cell matrix production
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2417 - 2424.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Pineyro, M. Azzi, A. deLean, P. W. Schiller, and M. Bouvier
Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human {delta}-Opioid Receptor with an Inverse Agonist
Mol. Pharmacol., January 1, 2005; 67(1): 336 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. S. Kang, K. Ryberg, M. Morgelin, and L. M. F. Leeb-Lundberg
Spontaneous Formation of a Proteolytic B1 and B2 Bradykinin Receptor Complex with Enhanced Signaling Capacity
J. Biol. Chem., May 21, 2004; 279(21): 22102 - 22107.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Wang, K. M. Raehal, E. T. Lin, J. J. Lowery, B. L. Kieffer, E. J. Bilsky, and W. Sadee
Basal Signaling Activity of {micro} Opioid Receptor in Mouse Brain: Role in Narcotic Dependence
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 512 - 520.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Kenakin
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Blaukat, P. Micke, I. Kalatskaya, A. Faussner, and W. Muller-Esterl
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1909 - H1916.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Schroeder, A. Breit, H. Boning, J. Dedio, L. Gera, J. Stewart, and W. Muller-Esterl
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1924 - H1932.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Duchene, J. P. Schanstra, C. Pecher, A. Pizard, C. Susini, J.-P. Esteve, J.-L. Bascands, and J.-P. Girolami
A Novel Protein-Protein Interaction between a G Protein-coupled Receptor and the Phosphatase SHP-2 Is Involved in Bradykinin-induced Inhibition of Cell Proliferation
J. Biol. Chem., October 18, 2002; 277(43): 40375 - 40383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. S. Kang and L. M. F. Leeb-Lundberg
Negative and Positive Regulatory Epitopes in the C-Terminal Domains of the Human B1 and B2 Bradykinin Receptor Subtypes Determine Receptor Coupling Efficacy to G9/11-Mediated Phospholipase Cbeta Activity
Mol. Pharmacol., August 1, 2002; 62(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. F. Leeb-Lundberg, D. S. Kang, M. E. Lamb, and D. B. Fathy
The Human B1 Bradykinin Receptor Exhibits High Ligand-independent, Constitutive Activity. ROLES OF RESIDUES IN THE FOURTH INTRACELLULAR AND THIRD TRANSMEMBRANE DOMAINS
J. Biol. Chem., March 16, 2001; 276(12): 8785 - 8792.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Blaukat, A. Pizard, A. Breit, C. Wernstedt, F. Alhenc-Gelas, W. Muller-Esterl, and I. Dikic
Determination of Bradykinin B2 Receptor in Vivo Phosphorylation Sites and Their Role in Receptor Function
J. Biol. Chem., October 26, 2001; 276(44): 40431 - 40440.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.